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Upon infection of human cells, the herpes simplex virus
protein VP16 associates with the endogenous cell-prolif-
eration factor HCF. VP16 can also associate with HCFs
from invertebrates, suggesting that VP16 mimics a cel-
lular protein whose interaction with HCF has been con-
served. Here, we show that VP16 mimics the human
basic leucine-zipper protein LZIP, which, through asso-
ciation with HCF, may control cell-cycle progression.
VP16 and LZIP share a tetrapeptide motif—D/EHXY—
used to associate with human HCF. The LZIP-related
Drosophila protein BBF-2/dCREB-A contains this HCF-
binding motif, indicating that the LZIP–HCF interaction
has been conserved during metazoan evolution.
Received August 25, 1997; accepted in revised form
September 18, 1997.
The initiation of herpes simplex virus (HSV) infection
involves the interaction of viral and cellular proteins.
The HSV virion carries the viral transactivator VP16
(also known as Vmw65 and aTIF), which is released into
the cell upon infection and associates with two cellular
factors—HCF and Oct-1—to initiate a cascade of viral
gene expression (for review, see Thompson and McK-
night 1992; O’Hare 1993). VP16 first associates with
HCF (also known as C1, VCAF, and CFF), a protein in-
volved in cell proliferation (Goto et al. 1997). HCF bind-
ing to VP16 promotes subsequent association with the
POU DNA-binding domain of the transcription factor
Oct-1 on the cis-regulatory target of VP16 activation: the
TAATGARAT motif found in HSV immediate-early pro-
moters. The interplay between viral and cellular ele-
ments afforded by this VP16-induced complex provides a
mechanism for coordination of HSV infection with the
state of the infected cell.
VP16 interacts with each of the other components in
the VP16-induced complex, the DNA, Oct-1, and HCF.
Two of these interactions, however, are not highly con-
served: VP16 from different herpesviruses differs in its
DNA-binding specificity (Huang and Herr 1996; Misra et
al. 1996), and VP16 associates poorly with mouse Oct-1,
which differs from human Oct-1 on the surface of the
POU domain critical for association with VP16 (Cleary
et al. 1993; Suzuki et al. 1993).
In contrast, the VP16–HCF interaction is highly con-
served: HCF from organisms as different as vertebrates
and invertebrates can associate with VP16 and stabilize
the VP16-induced complex (Kristie et al. 1989; Wilson et
al. 1993b). This conservation suggests that VP16 mimics
a cellular protein whose interaction with HCF is essen-
tial for viability in metazoans. Here, we describe the iso-
lation of such a candidate: the human basic leucine zip-
per (bZIP) protein LZIP. Strikingly, LZIP and a related
Drosophila protein called BBF-2 (Abel et al. 1992) or
dCREB-A (Smolik et al. 1992) share with VP16 a short
tetrapeptide motif used to associate with HCF.
Results
HCF is synthesized as a large precursor protein of ∼2000
amino acids, which is subsequently processed by prote-
olysis at multiple sites into amino- and carboxy-terminal
fragments, which remain noncovalently bound (Wilson
et al. 1993a, 1995b; Kristie et al. 1995). VP16 associates
with a 380-residue amino-terminal domain of HCF,
called the HCFVIC domain (Wilson et al. 1997). To iden-
tify human proteins that bind the HCFVIC domain, we
used the yeast two-hybrid assay (Fields and Song 1989) to
screen a human HeLa cell cDNA library for proteins able
to associate with a GAL4 DNA-binding domain (DBD)
fusion to the first 450 residues of HCF (DBD z HCFN450).
We identified three (out of 1 × 106) clones that interact
specifically with HCFN450. All three clones were derived
from the same human gene, encoding a bZIP protein re-
lated to the mouse protein LZIP, a protein of little
known biological function (Burbelo et al. 1994). We refer
to the human protein as human LZIP or hLZIP. A con-
temporaneous study by Lu et al. (1997) also identified
LZIP (referred to as Luman in that study) in a two-hybrid
screen for human HCF-interacting proteins.
Figure 1A shows the specificity of the HCFN450–hLZIP
interaction. Neither the DBD z HCFN450 fusion protein
nor a GAL4 transcriptional activation domain hLZIP fu-
sion (AD z hLZIP) activates the Gal1–His3 reporter on its
own (sectors A and E, respectively) or together with an
irrelevant partner (sectors B and F, respectively).
DBD z HCFN450 does, however, activate the GAL1–HIS3
reporter in the presence of AD z hLZIP (sector D)—as
does a VP16 activation domain fusion protein
(AD z VP16; sector C)—demonstrating specific HCFN450
interaction with LZIP.
Figure 1B compares the sequences of human and
mouse LZIP. Basic DNA-binding and leucine-zipper
dimer-formation regions typical of bZIP proteins are lo-
cated in the center of LZIP. These regions are 93% iden-
tical between human and mouse LZIP and include un-
usually long leucine-zipper segments with seven imper-
fect leucine heptad repeats. Outside of the basic leucine-
zipper region, the sequences are of similar size but
display less sequence identity.
In a Northern hybridization analysis (data not shown;
see also Lu et al. 1997), hLZIP mRNA was detected in all
tissues tested, suggesting that, like HCF (Wilson et al.
1995a), hLZIP is broadly expressed. Figure 1C shows that
the natural human HCF and LZIP proteins associate
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with one another: Immunoprecipita-
tion from a human 293-cell extract
with an anti-HCF antibody (lane 2),
but not with a nonspecific antibody
(lane 1), resulted in recovery of endog-
enous LZIP as evidenced in an immu-
noblot with anti-LZIP antisera.
The HCF tsBN67 cell proliferation
mutant fails to interact with LZIP
HCF is involved in promoting cell pro-
liferation: A single proline-to-serine
substitution at position 134 (P134S) of
the HCFVIC domain causes a tempera-
ture-sensitive cell cycle arrest (Goto et
al. 1997) and disrupts the ability of
VP16 to bind HCF (Wilson et al. 1997).
If VP16 mimics LZIP, LZIP should as-
sociate with the minimal 380-residue
HCFVIC domain (HCFN380), and the
tsBN67 mutation should prevent asso-
ciation. Figure 2 shows that these pre-
dictions are correct: In the two-hybrid
assay, VP16 and LZIP both interact
with wild-type HCFN380 (sectors B and
C, top) but not tsBN67 HCFN380 (sec-
tors B and C, bottom), even though
both the wild-type and tsBN67 HCF
fusion proteins were expressed at
similar levels as determined by immu-
noblot analysis (data not shown). The
tsBN67 effect on LZIP association
makes LZIP a candidate target of HCF
in controlling cell proliferation.
LZIP and VP16 associate similarly
with the HCFVIC domain
To contrast VP16 and LZIP associa-
tion with the HCFVIC domain more
extensively, we assayed the effects of a
systematic set of point mutations in
the HCFVIC domain on HCF associa-
tion with VP16 and LZIP. The HCFVIC
domain consists of six sequence re-
peats related to a repeat motif found in
the Drosophila protein Kelch, which
are called HCFKEL1 to HCFKEL6 (Wil-
son et al. 1997). Sequence similarity to
other proteins suggests that Kelch re-
peats form four-stranded b-sheets
which come together to form a propel-
ler-like structure, called a b-propeller,
in which each repeat resembles a blade
of the propeller (Bork and Doolittle
1994). The P134S tsBN67 mutation re-
places a proline in HCFKEL3 that is universally conserved
in all six repeats (Wilson et al. 1997) without affecting
HCF stability in vivo (Goto et al. 1997) or protease sen-
sitivity in vitro (R. Freiman and W. Herr, unpubl.).
Therefore, we assayed the effects of substituting the cor-
responding proline in each HCFKEL repeat with alanine
on association with LZIP and VP16, as shown in Figure 3.
Consistent with VP16 mimicry of the LZIP interaction
Figure 1. The bZIP protein LZIP interacts specifically with HCF. (A) Yeast two-hybrid
assays showing specificity of the HCF–LZIP interaction. Growth of the yeast GAL1–
HIS3 reporter strain transformed with both a Gal4 DNA-binding domain (DBD) fusion
expression plasmid and a Gal4 activation domain (AD) fusion expression plasmid is
shown. The identity of the fusion constructs is indicated in the diagram. Growth with
histidine (+histidine) demonstrates that the expression plasmids are not deleterious to
yeast growth, and growth without (−histidine) demonstrates activation of the GAL1–
HIS3 reporter gene. The yeast were grown for 7 days at 30°C in both the presence and
absence of histidine. (B) Amino acid sequence comparison of human LZIP (hLZIP) with
mouse LZIP (mLZIP; Burbelo et al. 1994) and two regions of the LZIP-related Drosophila
protein BBF-2/dCREB-A (Abel et al. 1992; Smolik et al. 1992, labeled dBBF-2). Sequence
identities to hLZIP are indicated by dots in the comparison. The DNA-binding basic
region and dimerization–interface leucine zipper are bracketed, with an asterisk above
the seven hydrophobic residues that make up the extended leucine zipper of LZIP. The
location of an additional 25 amino acids introduced by an alternate splice variant of
mouse LZIP (Burbelo et al. 1994) is indicated (.). The AD fusion points of the original
two-hybrid screen isolates are indicated by the arrows above the top line. (HBM) HCF-
binding motif. (C) Association of endogenous HCF and LZIP from human cells. Human
293 whole-cell nuclear extracts were precipitated with the nonspecific 12CA5 influenza
hemagglutinin monoclonal antibody (lane 1) or the M2 anti-HCF monoclonal antibody
(lane 2), and immunoblots of the precipitates were probed with the C7 LZIP antipeptide
antibody.
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with HCF, the HCFKEL repeat substitutions had parallel
effects on VP16 and LZIP association: Substitution of the
conserved proline in HCFKEL1 and HCFKEL5 had no evi-
dent effect on either LZIP or VP16 interaction with HCF
(sectors A and E), demonstrating that substitution of this
universally conserved proline by alanine does not neces-
sarily lead to universal disruption of the HCFVIC domain
structure. The HCFKEL2 and HCFKEL6 substitutions had
an intermediate effect on LZIP and VP16 interaction
(sectors B and F); only the HCFKEL3 and HCFKEL4 sub-
stitutions prevented effective LZIP or VP16 interaction
with the HCFVIC domain (sectors C and D). The domi-
nant effects of the mutations in HCFKEL3 and HCFKEL4
suggest that LZIP and VP16 bind the HCFVIC domain
assymetrically.
LZIP and VP16 share a tetrapeptide motif important
for association with HCF
VP16 and LZIP display little sequence similarity (data
not shown). There is, however, similarity to a short se-
quence in VP16—EHAY—that is involved in HCF asso-
ciation (Haigh et al. 1990; Hayes and O’Hare 1993; Wu et
al. 1994; Simmen et al. 1997; Lai and Herr 1997). As
shown in Figure 4A, this sequence is conserved in VP16
homologs from different herpesviruses, forming the con-
sensus sequence D/EHXY, where the first position can be
either aspartic or glutamic acid and the third position is
variable. The human and mouse LZIP sequences share
this tetrapeptide consensus [see Fig. 1B (labeled HBM)
and Fig. 4A].
To test the functional significance of this tetrapeptide
motif in LZIP, we compared the effect of individual
substitutions in a 9-amino-acid segment encompass-
ing the human LZIP and HSV VP16 D/EHXY motifs on
association with HCF. To measure association, we as-
sayed coimmunoprecipitation of epitope-tagged wild-
type and mutant LZIP and VP16 proteins with endog-
enous HCF after transient expression in human 293
cells, as shown in Figure 4B. Direct epitope tag immu-
noblot analysis of the extracts showed that the mutant
LZIP and VP16 proteins were expressed at levels similar
to their wild-type counterparts (lanes 1–10). Little pro-
tein, however, was recovered after immunoprecipitation
with an irrelevant antibody (lanes 21–30). Strikingly,
with both human LZIP and HSV VP16, mutation of the
same three positions—the first, second, and fourth posi-
tions of the D/EHXY motif—interfered with HCF asso-
ciation, whereas mutation of the other residues, includ-
ing the variable third position in the D/EHXY motif, did
not prevent LZIP or VP16 association with HCF (lanes
11–20). These results suggest that VP16 mimics a small
motif in LZIP—an HCF-binding motif (HBM)—to pro-
mote association with HCF. Consistent with this
hypothesis, VP16 and LZIP compete with one another
Figure 3. LZIP and VP16 recognize HCF similarly. Yeast two-
hybrid interactions between mutated HCFN380 and LZIP (top)
and VP16 (bottom). The DBD z HCFKEL 1–6 mutants (see dia-
gram) contain individual proline-to-alanine substitutions as fol-
lows: KEL1, P30A; KEL2, P79A; KEL3, P134A; KEL4, P197A;
KEL5, P252A; KEL6, P319A. The yeast were grown for 7 days at
30°C in both the presence (left) and absence (right) of histidine.
A control with wild-type DBD z HCFN380 with AD z LZIP and
AD z VP16 grown in parallel showed the same growth rate as the
cells grown in sectors A and E.
Figure 2. The HCF tsBN67 cell-cycle arrest mutation disrupts
interaction with LZIP. Yeast two-hybrid interaction assays with
wild-type HCFN380 (DBD z HCFN380, top panels) and tsBN67
HCFN380 (DBD z HCFN380P134S, bottom panels) were per-
formed as indicated in the diagram. The yeast were grown for 5
days at 30°C in both the presence (left) and absence (right) of
histidine.
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for association with HCF (Lu et al.
1997; C. Grozinger, R. Freiman, and
W. Herr, unpubl.).
A D/EHXY motif in Drosophila
BBF-2 promotes association
with HCF
The ability to interact with VP16 is
shared by metazoan HCFs (Kristie
et al. 1989; Wilson et al. 1993b),
suggesting that the HCF interac-
tion with a cellular protein mim-
icked by VP16 is conserved in ver-
tebrates and invertebrates. To test
this hypothesis, we asked whether
human HCF can associate with an
LZIP-related protein from Dro-
sophila. The known Drosophila
protein most closely related to
LZIP is the bZIP protein BBF-2
(Abel et al. 1992; also called
dCREB-A, Smolik et al. 1992); this
protein is 81% identical to human
LZIP in the basic region and shares
an extended imperfect leucine-zip-
per segment as shown in Figure 1B.
Outside of the bZIP region, BBF-2
shares only limited similarity to
the mammalian LZIP proteins, but
it does contain a consensus D/
EHXY motif near its amino termi-
nus as shown in Figures 1B and 4A.
Therefore, using the same assay
shown in Figure 4B, we tested na-
tive human HCF association with
both wild-type BBF-2 and a BBF-2
mutant containing a single alanine
substitution of the first position of
the D/EHXY motif, as shown in Fig-
ure 4C. In contrast to wild-type and
mutant human LZIP, a low level of
wild-type and mutant BBF-2 was re-
covered in the immunoprecipita-
tion with the irrelevant antibody
(lanes 5–8). Nevertheless, wild-type
LZIP and BBF-2 proteins were re-
covered more effectively than the
mutant forms after coprecipitation
with HCF (cf. lanes 1 and 2, and 3
and 4), suggesting that HCF can as-
sociate with BBF-2 through a D/
EHXY HCF-binding motif. To-
gether, the sequence similarity be-
tween LZIP and BBF-2 and their
common mode of interaction with
HCF suggest that LZIP and BBF-2
are homologs serving similar func-
tions in mammals and insects, such
as promoting cell proliferation.
Figure 4. Mammalian LZIP, Drosophila BBF-2, and VP16 share a small HCF-binding
motif. (A) HCF-binding motif sequence alignment. The VP16 sequences are derived from
homologs of VP16 from bovine herpesvirus (GenBank accession no. Z54206; BTIF), equine
herpesvirus (GenBank accession no. L16590), and varicella-zoster virus (GenBank acces-
sion no. X04370; ORF 10). Dots indicate sequence identities with the HSV VP16 (viral) and
hLZIP (cellular) sequences shown. The position of the carboxy-terminal residue within the
parental sequence is indicated to the right. The HCF-binding motif is boxed and a consen-
sus is shown at the bottom. (D/E) Either aspartic or glutamic acid; (X) nonconserved
variable residue. (B) HCF association with wild-type and mutant LZIP and VP16. Epitope-
tagged wild-type or nine substitution mutants of LZIP (top panels) and VP16 (bottom
panels) were transiently expressed in human 293 cells. The mutated residue in each mutant
is indicated above each lane. In LZIP, all residues were changed to alanine, except for the
threonine, which was changed to asparagine. In VP16, all nonalanine residues were
changed to alanine, and the alanine was changed to serine. Expression of each mutant
protein is shown by direct immunoblot with the anti-T7 epitope antibody of the 293 cell
extract (lanes 1–10). Extracts were precipitated with the N18 HCF antipeptide antibody
(lanes 11–20) or the nonspecific anti-N-Oct-3 antibody (lanes 21–30). In each panel, LZIP or
VP16 was detected by immunoblot analysis with the anti T7 epitope tag antibody. (C) HCF
recognizes the Drosophila BBF-2 HCF-binding motif. T7-epitope-tagged wild-type and mu-
tant LZIP and BBF-2 were transiently expressed in human 293 cells. Position 1 of the
HCF-binding motif in LZIP (D to A) and BBF-2 (E to A) were mutated (Mut). 293 cell
extracts were immunoprecipitated with the N18 HCF antibody (lanes 1–4) or the nonspe-
cific anti-N-Oct-3 (lanes 5–8) and the precipitates analyzed by immunoblot with the anti-
T7 epitope tag antibody. Direct immunoblot with the anti T7 epitope tag antibody showed
that for both LZIP and BBF-2 the wild-type and mutant proteins were expressed at the same
level, but the BBF-2 proteins were expressed at higher levels than LZIP (data not shown).
VP16 mimics a bZIP protein
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Discussion
We have identified related human and Drosophila bZIP
proteins that associate with the cell proliferation factor
HCF. The HSV regulatory protein VP16 mimics how
these proteins—LZIP in humans and BBF-2 in Dro-
sophila—associate with HCF: Like LZIP and BBF-2,
VP16 contains a short D/EHXY HCF-binding motif, and
LZIP and VP16 interactions with HCF are similarly af-
fected by mutations in HCF, including the temperature-
sensitive cell-cycle arrest mutation tsBN67. Because
LZIP and BBF-2 interact with HCF similarly and VP16
copies this interaction, perhaps the conserved LZIP and
BBF-2 interaction with HCF is the proposed conserved
cellular interaction mimicked by VP16. The association
with a bZIP protein implicates HCF in regulating cellu-
lar as well as viral patterns of gene transcription.
The common association with HCF suggests that LZIP
and BBF-2 are human and Drosophila homologs. Consis-
tent with this hypothesis the basic region DNA-binding
domains of LZIP and BBF-2 are closely related, and both
proteins contain unusually long and imperfect leucine-
zipper segments (see Fig. 1B). The closest related proteins
to LZIP and BBF-2 are cAMP response element-binding
(CREB) and activating transcription factor 1 (ATF-1) in
mammals and dCREB-B in Drosophila (for review, see
Hurst 1995), suggesting that the HCF-interacting LZIP
and BBF-2 proteins are members of a subfamily of bZIP
proteins that includes the CREB/ATF-1-related proteins.
Interestingly, both LZIP and CREB associate with large
nuclear proteins: HCF in the case of LZIP, and the tran-
scriptional coregulator CREB-binding protein (CBP) in
the case of CREB (Chrivia et al. 1993).
Although LZIP can bind to CREB- and other bZIP-
binding sites (Burbelo et al. 1994; Lu et al. 1997; C. Groz-
inger, R. Freiman, and W. Herr, unpubl.), the natural tar-
gets of LZIP regulation are unknown. In Drosophila, the
natural targets of transcriptional regulation by BBF-2 are
also not well understood, although disruption of the BBF-
2/dCREB-A gene in Drosophila has specific effects on
embryonic development (Andrew et al. 1997; Rose et al.
1997). Because LZIP fails to associate with the HCF cell-
cycle arrest mutation tsBN67, LZIP may be involved in
regulating cell-cycle progression together with HCF.
tsBN67 cells arrest in a G0- or early G1-like state, which
implicates HCF in preventing entry into G0 and/or pro-
moting passage through early G1 (Goto et al. 1997).
Thus, genes involved in progression through G0 and
early G1 are attractive targets of LZIP regulation.
One of the characteristics of the HCF tsBN67 pheno-
type is a delay of one or a few cell divisions before stable
growth arrest occurs (Goto et al. 1997). The implication
of HCF association with a transcription factor to regulate
cell-cycle progression offers an explanation for this phe-
notype: HCF and LZIP regulate—by activation or repres-
sion—expression of a gene whose product regulates cell-
cycle progression; when the HCF or LZIP interaction is
disrupted at the nonpermissive temperature by the tsBN67
mutation, the HCF–LZIP-regulated gene product has to be
depleted or inactivated before cell-cycle arrest can occur.
Unlike obligate lytic viruses, HSV can undergo either
a productive lytic infection or remain latent for long pe-
riods. VP16, which is important for initiating the cascade
of HSV gene expression that results in productive infec-
tion, may serve as a sensor by which the virus is able to
coordinate virus replication with the cell-cycle or differ-
entiation state of the infected cell. The requirement for
productive association with two cellular factors, Oct-1
and HCF, before VP16 can initiate HSV immediate-early
gene transcription suggests that it may be these interac-
tions with which VP16 senses the status of the cell. The
studies described here suggest that in both cases VP16 is
targeting the cellular transcriptional machinery: It asso-
ciates with Oct-1, a POU domain transcription factor
involved in histone and small nuclear RNA gene expres-
sion, and HCF, which is now implicated in regulating
transcription through association with LZIP. VP16 may
target the cellular transcriptional apparatus because this
machinery changes rapidly as it responds to or directs
changes in cell status.
Materials and methods
Yeast two-hybrid interaction assay
The GAL4 DNA-binding domain fusion expression plasmid pGBT9, con-
taining the TRP1 gene, was used to construct GAL4 DBD fusions (resi-
dues 1–94) to HCF (the pGDBD–HCF series). pGDBD–HCFN450
(DBD z HCFN450) and pGDBD–HCFN380 (DBD z HCFN380) contain hu-
man HCF residues 2–450 and 2–380, respectively. pGDBD–HCFN450 was
used to screen a human HeLa cDNA–GAL4 activation domain (AD; resi-
dues 768–881) fusion library constructed in pGADGH, which contains
the LEU2 gene (a gift of G. Hannon, Cold Spring Harbor Laboratory). Both
the DBD and AD plasmids were cotransformed in the reporter strain
Hf7c containing both GAL4-responsive his3 and lacZ reporter genes.
Yeast (1 × 106) transformants were screened for His+ growth. Of 41 His+
colonies recovered after 7–10 days growth at 30°C on synthetic media
plates lacking trytophan, leucine, and histidine, only 5 displayed activa-
tion of the lacZ reporter. The AD plasmids were recovered from these
five positives and retransformed into the reporter strain YGH1. Only
three clones (3-1, 4-1, and 9-1) activated the Gal1–His3 reporter in the
presence but not in the absence of the HCFN450 bait. Plasmids expressing
the GAL4 DBD (DBD z empty) or AD alone (AD z empty), or fused to the
yeast proteins SNF1 (DBD z SNF1) and SNF4 (AD z SNF4) were used as
negative controls (Fields and Song 1989).
Cloning full-length human LZIP
Sequence analysis revealed that two of the three HCF-interacting fusion
proteins were identical and that all three were AD fusions to either
residue 43 (3-1 and 9-1) or 54 (4-1) of the same mouse LZIP-related gene
(Burbelo et al. 1994). The full-length LZIP cDNA was cloned by PCR
amplification of a human lgt10 phage cDNA library with two nested
LZIP-specific primers and one l-specific primer. The extended 58 se-
quence revealed an in-frame initiator ATG codon; the sequence has been
deposited in GenBank (accession no. AF029674}.
Plasmid constructions and mutagenesis
The GAL4 DBD–HCF fusion constructs—the pGDBD–HCF series—are
all derived from pGBT9 but only encode GAL4 residues 1–94. This AD
fusion vector, pGADGHX2, a pGADGH derivative for in-frame insertion
of XbaI–BamHI fragments, was used to create pGADGHVP16DC
(AD z VP16), which contains VP16 residues 5–412 lacking the carboxy-
terminal VP16 activation domain, and pGADGHLZIPFL (AD z LZIP)
which contains LZIP residues 2–371. In Figure 1A, the AD z LZIP con-
struct contains residues 43–371 (clone 3-1). T7-epitope-tagged VP16,
LZIP, and BBF-2 were expressed from pCGT plasmids. VP16 was ex-
pressed from pCGTVP16DC (Wilson et al. 1997). pCGTLZIPFL contains
hLZIP residues 2–371, and pCGTBBF-2FL contains Drosophila BBF-2 resi-
dues 2–515. Amino acid substitutions were generated by oligonucleotide-
directed mutagenesis as described previously (Kunkel et al. 1987).
Freiman and Herr
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Antisera and immunoprecipitation
The C7 anti-LZIP antiserum was raised in rabbits against the octapeptide
CLQDRYSG containing the carboxy-terminal 7 amino acids of hLZIP
(underlined) coupled to keyhole limpet hemocyanin and inoculated into
rabbits as described (Atanasoski et al. 1997). The N18 anti-peptide HCF
(Goto et al. 1997) and N-Oct 3 (Atanasoski et al. 1997) antisera and M2
anti-HCF monoclonal antibody (Wilson et al. 1995a) have been described
previously. To assay endogenous HCF and LZIP interaction, human 293
extracts were prepared in extraction buffer (200 mM KCl, 100 mM Tris at
pH 8.0, 10% glycerol, 0.1% NP-40, 20 mM EDTA, and 1 mM PMSF). A
1:50 dilution of the anti-HCF monoclonal antibody M2 (Wilson et al.
1995a) was incubated with the extract for 90 min at 4°C with rotation.
Immune complexes were recovered with protein G–agarose beads,
washed four times in the same buffer without glycerol and 0.05% NP-40,
and resolved by 12% SDS-PAGE for immunoblot analysis. A 1:1000 di-
lution of the C7 LZIP antiserum was used to probe the immunoblot.
Transient expression, coprecipitation, and immunoblotting
To express T7 epitope-tagged LZIP, VP16, and BBF-2 proteins, pCGTL-
ZIPFL (20 µg), pCGTVP16DC (0.2 µg), and pCGTBBF-2FL (2.0 µg) were
transfected into human 293 cells by electroporation, and extracts pre-
pared 36 hr post-transfection as described (Wilson et al. 1997) in 1 ml of
extraction buffer containing 1.0% NP-40, 0.5% DOC, and 0.1% SDS. The
anti-HCF N18 or anti-N-Oct 3 polyclonal sera were cross-linked to pro-
tein A–agarose as described (Harlow and Lane 1988). Ten microliters of
antibody beads (50% slurry) was added to 200 µl of extract and incubated
for 90 min at 4°C, recovered by centrifugation, and washed three times in
extraction buffer. Immune complexes were resolved on a 10% SDS-
PAGE and immunobots probed with the anti-T7 epitope tag monoclonal
antibody (Novagen) at a 1:5000 dilution. The levels of T7 epitope-tagged
LZIP and VP16 expression were assayed by direct immunoblotting of
1/20 and 1/100 of the extract, respectively.
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